Evidence map›Paper›PMID 33044866›Full record

ArticleAmerican journal of physiology. Renal physiology2020

Using best subset regression to identify clinical characteristics and biomarkers associated with sepsis-associated acute kidney injury.

Y Diana Kwong, Kala M Mehta, Christine Miaskowski, Hanjing Zhuo, Kimberly Yee, Alejandra Jauregui, Serena Ke, Thomas Deiss, Jason Abbott, Kirsten N Kangelaris and 7 more

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Y Diana KwongDivision of Nephrology, Department of Medicine, University of California, San Francisco, California.ORCID 0000-0001-5772-8148
Kala M MehtaDepartment of Epidemiology and Biostatistics, University of California, San Francisco, California.
Christine MiaskowskiDepartment of Physiological Nursing, University of California, San Francisco, California.
Hanjing ZhuoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Kimberly YeeDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Alejandra JaureguiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Serena KeDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Thomas DeissDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Jason AbbottDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Kirsten N KangelarisDivision of Hospital Medicine, Department of Medicine, University of California, San Francisco, California.
Pratik SinhaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Carolyn HendricksonDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Antonio GomezDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Aleksandra LeligdowiczDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Michael A MatthayCardiovascular Research Institute, Department of Medicine and Department of Anesthesia, University of California, San Francisco, California.
Carolyn S CalfeeDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, California.
Kathleen D LiuDivision of Nephrology, Department of Medicine, University of California, San Francisco, California.

Funding

Precision Medicine in the Acute Respiratory Distress SyndromeR35HL140026 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CALFEE, CAROLYN · 2018 to 2024
$6.8M
Acute Respiratory Distress Syndrome after Isolated Traumatic Brain Injury: Platelet Biology, Endothelial Activation, and Mechanical VentilationK23HL133495 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HENDRICKSON, CAROLYN MARIE · 2016 to 2020
$994k
Advancing acute kidney injury phenotyping using biological and clinical criteriaK24DK113381 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIU, KATHLEEN D · 2017 to 2021
$915k
Identification of Sub-phenotypes in Sepsis Associated Acute Kidney InjuryF32DK118870 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KWONG, YUENTING DIANA · 2018 to 2020
$163k
NHLBI NIH HHS K23 HL133495NHLBI NIH HHS R35 HL140026NIDDK NIH HHS F32 DK118870NIDDK NIH HHS K24 DK113381
6 · The paper itself

Abstract

Sepsis-associated acute kidney injury (AKI) is a complex clinical disorder associated with inflammation, endothelial dysfunction, and dysregulated coagulation. With standard regression methods, collinearity among biomarkers may lead to the exclusion of important biological pathways in a single final model. Best subset regression is an analytic technique that identifies statistically equivalent models, allowing for more robust evaluation of correlated variables. Our objective was to identify common clinical characteristics and biomarkers associated with sepsis-associated AKI. We enrolled 453 septic adults within 24 h of intensive care unit admission. Using best subset regression, we evaluated for associations using a range of models consisting of 1-38 predictors (composed of clinical risk factors and plasma and urine biomarkers) with AKI as the outcome [defined as a serum creatinine (SCr) increase of ≥0.3 mg/dL within 48 h or ≥1.5× baseline SCr within 7 days]. Two hundred ninety-seven patients had AKI. Five-variable models were found to be of optimal complexity, as the best subset of five- and six-variable models were statistically equivalent. Within the subset of five-variable models, 46 permutations of predictors were noted to be statistically equivalent. The most common predictors in this subset included diabetes, baseline SCr, angiopoetin-2, IL-8, soluble tumor necrosis factor receptor-1, and urine neutrophil gelatinase-associated lipocalin. The models had a c-statistic of ∼0.70 (95% confidence interval: 0.65-0.75). In conclusion, using best subset regression, we identified common clinical characteristics and biomarkers associated with sepsis-associated AKI. These variables may be especially relevant in the pathogenesis of sepsis-associated AKI.

Indexed as

Acute Kidney InjuryAgedAged, 80 and overBiomarkersCritical IllnessFemaleHumansMaleMiddle AgedModels, BiologicalSepsisBiomarkersacute kidney injurybiomarkerssepsis

Identifiers

PMID33044866
PMCPMC7792692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.